]i), the regulatory pathways have not been elucidated. Protein kinase C (PKC) contributes to ATPmediated secretion in BECs, although its potential role in TMEM16A regulation is unknown. To determine whether PKC␣ regulates the TMEM16A-dependent membrane Cl Ϫ transport in BECs, studies were performed in human biliary Mz-cha-1 cells. Addition of extracellular ATP induced a rapid translocation of PKC␣ from the cytosol to the plasma membrane and activation of whole cell Ca 2ϩ -activated Cl Ϫ currents. Currents demonstrated outward rectification and reversal at 0 mV (properties consistent with TMEM16A) and were inhibited by either molecular (siRNA) or pharmacologic (PMA or Gö6976) inhibition of PKC␣. Intracellular dialysis with recombinant PKC␣ activated Cl Ϫ currents with biophysical properties identical to TMEM16A in control cells but not in cells after transfection with TMEM16A siRNA. In conclusion, our studies demonstrate that PKC␣ is coupled to ATP-stimulated TMEM16A activation in BECs. Targeting this ATP-Ca 2ϩ -PKC␣ signaling pathway may represent a therapeutic strategy to increase biliary secretion and promote bile formation.
TMEM16A; PKC␣; ATP; Cl Ϫ channel; cholangiocytes INTRAHEPATIC BILIARY EPITHELIAL CELLS (BECs), also known as cholangiocytes, contribute to bile formation through the secretion of electrolytes and water. Cl Ϫ channels on the apical, or luminal, membrane of BECs provide the driving force for secretion (17) . We have recently identified TMEM16A (also known as Ano1 or Anoctamin 1) as a Ca 2ϩ -activated Cl Ϫ channel in the apical membrane of BECs (6, 9) . TMEM16A is activated by increases in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) through a process involving extracellular ATP binding membrane P2 receptors (9) . Importantly, in BECs the magnitude of ATP-stimulated Cl Ϫ currents mediated by TMEM16A is approximately threefold greater than that stimulated by increases in cAMP (mediated by CFTR) (6, 8) . Additionally, in polarized epithelial monolayers, the short circuit current (I sc ) response, a reflection of transepithelial Cl Ϫ movement, is approximately fourfold greater in response to ATP added to the apical membrane than to stimuli that increase cAMP (8) . Together, these findings suggest that ATP-stimulated Cl Ϫ currents mediated by TMEM16A are the predominant Cl Ϫ currents in BECs. However, the regulatory pathways responsible for TMEM16A activation are largely unknown.
TMEM16A is a 114-kDa membrane protein with eight putative transmembrane domains and is activated by increases in [Ca 2ϩ ] i (4, 30, 38) . However, the mechanism by which Ca 2ϩ activates the channel is not entirely clear. Previous studies have suggested that Ca 2ϩ interacts with calmodulin at calmodulinbinding domains on the channel protein (18, 32) . More recent studies, however, have suggested that Ca 2ϩ binds specific amino acids on the channel protein directly to modulate anion permeability independent of calmodulin (40, 41) . The differences in Ca 2ϩ sensitivity between species and different cell types therefore is unexplained but may involve other factors that alter the Ca 2ϩ sensitivity of the channel. Interestingly, TMEM16A contains several putative PKC phosphorylation sites that are near potential sites of Ca 2ϩ binding (20) . Furthermore, stimuli that are associated with increases in TMEM16A activity, such as shear force or membrane distention, are also associated with activation or translocation of PKC to the plasma membrane (26, 35, 39 . Atypical isoforms (, ) lack C2 domains and have an atypical C1 domain and are regulated independently of Ca 2ϩ or DAG (31) . BECs express multiple PKC isoforms, including conventional, novel, and atypical isoforms (25) . Among the conventional PKCs, PKC␣ is the predominant Ca 2ϩ -and phorbol-sensitive isoform present in BECs, while ␤ I , ␤ II , and ␥ are present in trace amounts only (33) . Given that specific stimuli that increase both ATP release (with subsequent increases in [Ca 2ϩ ] i ) and Cl Ϫ channel activity are associated with PKC translocation from cytosol to plasma membrane (26, 34) , we hypothesized that ATP-stimulated TMEM16A activity is mediated by both Ca 2ϩ and the Ca 2ϩ -dependent isoform of PKC PKC␣.
Therefore, the purpose of these studies was to assess the role of the conventional PKC isoform PKC␣ as a potential signaling molecule mediating biliary epithelial cell Cl Ϫ secretion by linking ATP receptor binding to TMEM16A channel activation.
EXPERIMENTAL PROCEDURES
Cell culture. Studies were performed in human Mz-Cha-1 cells originally isolated from human cholangiocarcinoma (19) . These cells exhibit phenotypic features characteristic of differentiated biliary epithelium (3, 19) and have been utilized as models for purinergic signaling and Ca 2ϩ -dependent secretion (6 -8, 15, 28, 33) . Importantly, they express TMEM16A, P2 receptors, and both Ca 2ϩ -dependent and atypical PKC isoforms (6, 19, 25, 36) .
TMEM16A expression. TMEM16A mRNA was detected by quantitative real-time PCR using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Life Technologies, Carlsbad, CA). Amplification reactions were performed in a final volume of 10 l containing cDNA from 10 ng of reverse transcribed total RNA, 150 nM each of forward and reverse primers (forward: CGGAAACA-GATGCGACTCAAC and reverse: TGATCCTTGACAGCCTC-CTCTT) and SYBR Green PCR Master Mix (Applied Biosystems). TMEM16A protein was detected by Western blotting utilizing goat polyclonal TMEM16A (S-20: sc-69343) or rabbit polyclonal TMEM16A antibody (H-41: sc-135235; Santa Cruz Biotechnology, Santa Cruz, CA). Signals were visualized using enhanced chemiluminescence detection (Pierce Biotechnology, Rockford, IL), specific signals were captured digitally (Chemigenius2 photo-documentation system; Syngene, Cambridge, UK), and band intensity was quantified using standard software (GeneTool; Syngene) or ImageJ (National Institutes of Health).
TMEM16A and PKC␣ silencing. TMEM16A expression was inhibited using specific TMEM16A siRNA (TMEM16A-HSS123904). Duplexes of 25-nucleotide of siRNA were designed and synthesized by Invitrogen [AAG UUA GUG AGG UAG GCU GGG AAC C (antisense); GGU UCC CAG CCU ACC UCA CUA ACU U (sense)] and transfected using Fu-gene (5 g/100 l) or Lipofectamine RNAi Max (using company protocol). Noncoding StealthTM RNAi (medium GC duplex; Invitrogen) was utilized in control (mock) transfections. Similarly, PKC␣ expression was inhibited using specific PKC␣ siRNA (PKC␣-s11094). Duplexes of 21-nucleotide of Silencer select siRNA were designed and synthesized by Ambion [GGCUGUACUUCGUCAUGGAtt (sense); UCCAUGACGAAGUAACAGCCga (antisense)]. Silencer select negative control #2 siRNA was used as control. Block-it Fluorescent Oligo (catalog no. 2013) from Invitrogen was used to optimize transfection conditions and for selection of transfected cells for whole cell patch-clamp current recording. Experiments were performed 24 -48 h after transfection. Transfection efficiency and degree of TMEM16A and PKC␣ silencing were evaluated at message level by real-time PCR and at the protein level by Western blot analysis (6, 9) .
PKC translocation. The cytosolic and membrane fractions from Mz-Cha-1 cells were prepared according to the protocol in the Qiagen Qproteomecell compartment kit (Qiagen). Lysates from different fractions were resolved in 4 -12% gradient SDS-PAGE and electroblotted on nitrocellulose membranes. Western blot analysis was performed using the mouse monoclonal anti-PKC␣ antibody (sc-8393; Santa Cruz Biotechnology). ]i was calculated using software kindly provided by Guy Droogmans (Guy.Droogmans@med.KULeuven.ac.be). In the select studies utilizing intracellular dialysis of PKC␣, 50 nM phorbol 12-myristate 13-acetate (PMA) and 1 mM MgATP were also included in the patch pipette to serve as cofactors for phosphorylation. During these intracellular dialysis studies, suramin (100 M) was included in the bath to negate any effects of ATP on membrane P2 receptors. Patch pipettes were pulled from Corning 7052 glass and had a resistance of 2-5 M⍀. Recordings were made with an Axopatch ID amplifier (Axon Instruments, Foster City, CA) and were filtered at 2 kHz and sampled at 4 kHz for storage on a computer and analyzed using pCLAMP version 10 (Axon Instruments, Burlingame, CA) as previously described (6, 22) . Two voltage protocols were utilized: 1) holding potential Ϫ40 mV, with 100-ms steps to 0 and Ϫ80 mV at 10-s intervals (for real-time tracings), and 2) holding potential Ϫ40 mV, with 400-ms steps from Ϫ100 to ϩ100 mV in 20-mV increments. Current-voltage (I-V) relations were generated from the "step" protocol. Results are compared with control studies measured on the same day to minimize any effects of day-to-day variability and reported as current density (pA/pF) to normalize for differences in cell size (6, 7) . Concentration-response data for [Ca 2ϩ ]i activation of whole cell currents were fitted to the following equation:
Measurement of Cl
Where Y is the current density, X is free [Ca 2ϩ ]i, Vmax is the maximum current density at Ϫ80 mV, K is the half maximum concentration of free [Ca 2ϩ ]i, and n is the Hill coefficient. Reagents. Gö6976 was obtained from LC Laboratories (Woburn, MA). All other reagents, including recombinant PKC␣ and ATP, were obtained from Sigma-Aldrich (St. Louis, MO).
Statistics. Results are presented as the means Ϯ SE, with n representing the number of culture plates or repetitions for each assay as indicated. Student's paired or unpaired t-test or ANOVA for multiple comparisons was used to assess statistical significance as indicated, and P Ͻ 0.01 or 0.05 was considered to be statistically significant.
RESULTS

Pharmacologic inhibition of PKC blocks Ca 2ϩ -activated Cl
Ϫ currents. To determine if Ca 2ϩ -activated Cl Ϫ currents are dependent on PKC, whole cell patch-clamp studies were performed in Mz-Cha-1 cells in the presence or absence of PKC inhibition. Under whole cell patch-clamp conditions, the intracellular Ca 2ϩ concentration was increased directly by addition of 1 M of free Ca 2ϩ in the patch-pipette. As shown in Fig. 1A , increasing intracellular free Ca 2ϩ from 100 nM to 1 M resulted in the gradual onset of currents, increasing current density from Ϫ4.0 Ϯ 2.0 to Ϫ50 Ϯ 8.1 pA/pF (Fig. 1, A and B). Currents demonstrated time-dependent activation at positive potentials (greater than ϩ60 mV), outward rectification, and reversal at 0 mV (E Cl Ϫ ϭ 0) consistent with the properties of TMEM16A (4, 6, 9, 30, 38) . In contrast, addition of the conventional PKC inhibitor Gö6976 to the perfusate abolished the Ca 2ϩ -activated Cl Ϫ currents. Additionally in separate studies, overnight incubation with PMA, to downregulate conventional and phorbol-sensitive PKC activity, also inhibited Ca 2ϩ -activated Cl Ϫ currents (Fig. 2) . We have previously shown in mouse, rat, and human BECs that extracellular ATP increases [Ca 2ϩ ] i through stimulation of membrane purinergic (P2) receptors and activates Cl Ϫ currents (6, 8, 9) . To determine if ATP-stimulated Cl Ϫ currents are dependent on PKC, whole cell patch-clamp studies were performed in single cells in the presence or absence of PKC inhibition. Under whole cell patch-clamp conditions, exposure of cells to ATP (100 M) resulted in activation of Cl Ϫ currents within 1 min (Fig. 1C) . The biophysical properties of ATPstimulated currents demonstrated time-dependent activation at positive potentials, outward rectification, and a reversal potential at 0 mV (E Cl Ϫ ϭ 0), properties consistent with TMEM16A channels (4, 6, 9, 30, 38) . In contrast, addition of the conventional PKC inhibitor Gö6976 to the perfusate abolished the ATP-stimulated Cl Ϫ currents (Fig. 1, C and D) . Likewise, overnight incubation with PMA abolished Ca 2ϩ -activated Cl Ϫ currents (Fig. 2) . Collectively, these results demonstrate . Currents measured at Ϫ80 mV (OE), representing IClϪ, and at 0 mV (), representing IKϩ, are shown. The voltage-step protocol (500-ms steps from Ϫ100 to ϩ100 mV in 20-mV increments) was obtained at aଝ and bଝ as indicated and used to generate the I-V relation during initial () and maximal-stimulated (OE) conditions. C: cumulative data demonstrating maximal current density (ϪpA/pF) in control conditions and after overnight incubation with PMA (1 M) measured at Ϫ80 mV (n ϭ 6 -7). *P Ͻ 0.01 vs. basal; **P Ͻ 0.05 vs. PMA (1 M).
that the Ca 2ϩ -and ATP-stimulated Cl Ϫ currents are dependent on conventional, Ca 2ϩ -dependent isoforms of PKC. It should be noted that in some trials, ATP caused a transient upward deflection of the current trace consistent with opening of Ca 2ϩ -activated K ϩ channels, which we have previously identified in BECs as mediated in part by SK2 and IK1 (7, 11) .
Molecular silencing of PKC␣ inhibits ATP-stimulated Cl Ϫ currents. To confirm the specific role of PKC␣ in ATPstimulated Cl Ϫ channel regulation, we performed whole cell patch-clamp studies in control cells and in cells after molecular silencing of PKC␣ by siRNA. As shown in Fig. 3 , transfection of cells with PKC␣ siRNA decreased expression of PKC␣ protein by 66.8 Ϯ 25.6% which was associated with a parallel decrease in the magnitude of whole cell Cl Ϫ currents by 74.1 Ϯ 27.1% in response to extracellular ATP (100 M) compared with cells transfected with nontargeting siRNA (mock; Fig. 3 ).
Exposure to extracellular ATP results in rapid translocation of PKC␣ to the plasma membrane. Given the above results, we sought to determine if acute exposure to ATP results in translocation of PKC␣ from the cytosol to the plasma membrane. Under basal conditions, PKC␣ was mainly present in cytosol (Fig. 4A) . After application of ATP, PKC␣ translocated to the plasma membrane within 1 min as demonstrated by enrichment of PKC␣ in the plasma membrane fraction (Fig.  4, A and B) . This rapid translocation corresponds to the onset of Cl Ϫ currents by exposure to ATP, which occurred within 85.7 Ϯ 12.2 s. The enrichment of the plasma membrane fraction with PKC␣ was transient and returned to basal expression levels by 10 min.
As ATP exerts cellular effects through binding P2 receptors and increases in [Ca 2ϩ ] i , the effects of P2 receptor blockade or Ca 2ϩ chelation on PKC␣ translocation was evaluated. As expected, in the presence of the P2 receptor antagonist suramin, the ATP-stimulated translocation of PKC␣ from the cytosol to the plasma membrane was not observed (Fig. 4C) . In a similar manner, chelation of intracellular Ca 2ϩ with BAPTA-AM decreased the membrane fraction of PKC␣ (Fig.  4C) . Together, these results demonstrate that there is rapid and dynamic trafficking of PKC␣ to the plasma membrane in response to acute exposure to extracellular ATP that is dependent on intracellular Ca 2ϩ and within a time frame that parallels activation of Cl Ϫ currents, suggesting a potential direct effect by PKC␣ on plasma membrane Cl Ϫ channels. Intracellular dialysis with recombinant PKC␣ activates Cl Ϫ currents. To directly assess the role of PKC␣ in membrane Cl Ϫ channel activation, recombinant human PKC␣ was delivered to the cell interior by inclusion in the patch pipette during whole cell recording conditions. Whole cell currents remained small in control cells (Fig. 5) . In contrast, spontaneous activation of currents was observed with intracellular dialysis with PKC␣ (60 ng/ml). The PKC␣-stimulated currents exhibited characteristics of the Ca 2ϩ -activated Cl Ϫ currents with reversal at 0 mV (E Cl Ϫ), outward rectification, and time-dependent activation at depolarizing potentials above ϩ60 mV. Moreover, the currents activated by intracellular dialysis with PKC␣ were significantly inhibited by Gö6976. To provide evidence that the activation of Cl Ϫ currents by recombinant PKC␣ is "downstream" of ATP binding P2 receptors, i.e., linking P2 receptor stimulation with channel activation and not due to indirect effects on ATP release, whole cell currents were measured in response to intracellular dialysis with PKC␣ in the presence or absence of the P2 receptor antagonist suramin. If PKC-activated currents were due to indirect effects of PKC on ATP release, and subsequent binding to P2R, inclusion of the P2R inhibitor suramin would be expected to abolish the currents in response to intracellular dialysis with PKC␣. As shown in 
PKC␣ activated Cl
Ϫ currents similar to control conditions (without suramin). This finding indicates that PKC␣ activates Cl Ϫ currents through direct effects on channel opening and not through indirect effects on ATP release. Together, the results are consistent with a model in which PKC␣ is downstream of ATP-P2 receptor binding and couples P2 receptor activation to opening of Ca 2ϩ -activated Cl Ϫ channels.
Synergism of Ca 2ϩ and PKC␣ in the activation of Cl
Ϫ currents. As shown in Fig. 1 Fig. 7 , current density increased as the concentration of free Ca 2ϩ in the patch pipette increased. In control cells, increasing [Ca 2ϩ ] i resulted in an increase in the magnitude of currents with maximum current activation observed at 1 M. When PKC␣ was dialyzed into the cell interior, the magnitude of the Ca 2ϩ -activated currents increased at every concentration of Ca 2ϩ with maximum current activation observed at 500 nM. As shown in Fig. 7 , the activation curve was shifted to the left. The half-maximal effective concentration (EC 50 ) of Ca 2ϩ required for channel activation was 349.4 Ϯ 9.5 nM in control cells; however, in the presence of PKC␣ the EC 50 of Ca 2ϩ for maximal channel activation was lowered to 62.8 Ϯ 3.9 nM (Fig. 7) . Thus PKC␣ appears to work in a cooperative manner to lower the [Ca 2ϩ ] i threshold necessary for maximal current activation; conversely, Ca 2ϩ may directly increase activation of the added PKC␣ resulting in an increase in channel open probability.
PKC␣-activated currents are mediated by TMEM16A.
We have recently shown that Ca 2ϩ -activated Cl Ϫ currents are mediated by TMEM16A channels in mouse, rat, and human biliary epithelium, including Mz-Cha-1 cells (6, 9) . In biliary epithelium, TMEM16A is located predominantly in the apical membrane and is activated in response to exposure to extracellular ATP (6) . To confirm that the Cl Ϫ currents observed with intracellular dialysis of PKC␣ are mediated by TMEM16A, cells were transfected with either TMEM16A siRNA or a nontargeting siRNA for 24 -48 h. Transfection of cells with TMEM16A siRNA significantly decreased expression of TMEM16A mRNA and protein as previously observed (6, 9) (Fig. 8) and significantly inhibited Cl Ϫ currents in response to intracellular dialysis with PKC␣ compared with cells transfected with nontargeting siRNA or nontransfected cells (Fig. 8) . Together, these data demonstrate that TMEM16A channels contribute to the PKC␣-activated Cl Ϫ currents in human biliary cells.
DISCUSSION
Purinergic (P2) signaling along the apical membrane of duct cells has emerged as an important pathway contributing to liver bile formation (12) . Released into bile by both hepatocytes and cholangiocytes (15, 16) , ATP binds P2 receptors on the apical membrane of cholangiocytes resulting in increases in [Ca 2ϩ ] i and Ca 2ϩ -activated Cl Ϫ channel activity (6, 15, 16, 27) . The increase in luminal Cl Ϫ concentration drives Cl Ϫ /HCO 3 Ϫ exchange through AE2 (2) and water efflux through aquaporin 4 (23) . The end result is an increase in the alkalinization and dilution of ductular bile. The P2 signaling pathway also represents a novel form of regulation in which ATP and nucleotides in bile directly regulate ductular transport through interactions with receptors on the apical membrane. The recent identification of TMEM16A as the downstream Cl Ϫ channel activated in response to apical receptor binding by ATP (6) suggests that this channel may represent a therapeutic target to promote Cl Ϫ efflux and HCO 3 Ϫ transport to promote bile flow in the treatment of cholestatic disorders.
In the current studies, utilizing a human biliary cell model, we have demonstrated that the conventional and Ca 2ϩ -dependent PKC isoform PKC␣ regulates ATP-stimulated TMEM16A channel activity. This is based on our findings that 1) the ATP-stimulated Cl Ϫ currents are abolished by GÖ6976, a specific inhibitor of conventional PKC isoforms; 2) ATP binding results in rapid translocation of PKC␣ from the cytosol to the plasma membrane; 3) intracellular dialysis with recombinant PKC␣ activates Cl Ϫ currents with identical biophysical properties to TMEM16A; 4) PKC␣ facilitates the activation of currents by [Ca 2ϩ ] i in a synergistic manner; and 5) transfection of cells with TMEM16A siRNA significantly decreased TMEM16A protein expression and was associated with a significant decrease in the magnitude of Cl Ϫ currents in response to intracellular dialysis with recombinant PKC␣. Together, these results demonstrate that PKC␣ is a critical signal linking P2 receptor stimulation to TMEM16A channel activation. Based on these findings and our previous work, we propose a model in which binding of P2 receptors by ATP results in release of Ca 2ϩ from intracellular stores (8) , rapid translocation of PKC␣ to plasma membrane targets, and a decrease in the EC 50 of Ca 2ϩ required for TMEM16A channel activation.
It should be noted that if these studies in a model biliary cell line apply to in vivo conditions, several questions and considerations remain. First, the specific site of PKC␣ action on TMEM16A is not defined. While PKC␣ has been associated with ATP release in other cell types, including hepatocytes and cholangiocytes (14, 29) , the current studies do not support a role in ATP release and channel activation but rather a "downstream" cellular pathway linking P2 receptor activation to channel activity. Potentially, this could occur through a direct effect on the channel through phosphorylation or through activation of other regulatory molecules necessary for channel opening. TMEM16A is a protein of ϳ960 amino acids and contains several potential PKC phosphorylation sites (4, 20) . In fact, in other cell models PKC has been shown to directly modulate channel function (1, 24) . Thus the possibility of The voltage-step protocol (400-ms steps from Ϫ100 to ϩ100 mV in 20-mV increments) was obtained at ଝa and ଝb as indicated and used to generate the I-V relation during initial () and PKC␣-stimulated conditions in presence of suramin (OE). B: cumulative data demonstrating the peak current density (ϪpA/pF) in response to intracellular dialysis with PKC␣ in the presence or absence of suramin (100 M) measured at Ϫ80 mV; n ϭ 4 -5 each, n.s. ϭ not significant. *P Ͻ 0.01 vs. basal. In these select studies, 50 nM PMA and 1 mM MgATP were also included in the patch pipette to serve as cofactors for phosphorylation. Currents measured at Ϫ80 mV (OE), representing IClϪ, and at 0 mV (), representing IKϩ, are shown. Horizontal bar above the trace indicates application of the PKC inhibitor Gö6976 (10 M) in the bath solution. The voltage-step protocol (400 ms steps from Ϫ100 to ϩ100 mV in 20-mV increments) was obtained at ଝa, ଝb, and ଝc as indicated and used to generate the I-V relation, representing initial (basal) () and maximal PKC␣-stimulated currents during control conditions (OE) and in the presence of Gö6976 (p). Cumulative data show the magnitude of PKC␣-stimulated currents, reported as current density (ϪpA/pF) in presence or absence of Gö6976 (10 M) measured at Ϫ80 mV (B) (n ϭ 5). *P Ͻ 0.01 vs. basal. **P Ͻ 0.01, PKC␣-stimulated currents are significantly inhibited by Gö6976 and PKC␣ significantly increases whole cell currents. direct TMEM16A channel phosphorylation by PKC␣ in BECs is a likely regulatory event, although it requires further study. Conversely, it is possible that PKC␣ interacts with other kinases or regulatory molecules in a signaling cascade that modulates TMEM16A function. For instance, CaMKII, a regulator of Ca 2ϩ -activated Cl Ϫ channels in other cell types, has been observed to interact with PKC (37) . However, recent studies suggest that TMEM16A is not regulated by CaMKII or calmodulin but rather interacts with Ca 2ϩ directly through specific amino acids in the channel protein (40, 41) . This is consistent with our findings demonstrating a synergistic and additive effect of Ca 2ϩ and PKC␣ on channel activation independent of calmodulin or CaMKII. Essentially, PKC␣ lowers the EC 50 of [Ca 2ϩ ] i required for full channel activation. Lastly, the possibility that PKC plays a role in vesicular trafficking and regulates the recruitment of TMEM16A containing vesicles to the plasma membrane in response to ATP cannot be excluded. In fact, PKC has been shown to directly modulate the membrane dwell time of other channel proteins including TRP Ca 2ϩ channels (24) . Second, the mechanism that regulates the translocation of PKC to the membrane in response to ATP in BECs is unknown. Presumably, store-operated Ca 2ϩ release, as a result of ATP binding the G-protein-linked P2Y receptor with IP 3 gen- (10, 200 , and 500 nM; shown at left) and corresponding I-V relation (plotted at right) in the absence (A) or in the presence (B) of PKC␣ (60 ng/ml) in dialyzing pipette. C: [Ca 2ϩ ]i dose-response curve for Cl Ϫ currents. Data were plotted from maximum current density (pA/pF) measured at Ϫ80 mV in response to different intracellular (pipette) Ca 2ϩ concentrations in absence () or in presence (OE) of PKC␣ (60 ng/ml) in dialyzing pipette. Each point represents means Ϯ SE; n ϭ 4 -5 with PKC␣, and n ϭ 3-11 without PKC␣; fit to the Hill equation (see EXPERIMENTAL PROCEDURES); n ϭ 4 -5 each. *P Ͻ 0.05 vs. absence of PKC␣. Fold of TMEM16A * Fig. 8 . PKC␣-stimulated Cl Ϫ currents are mediated through TMEM16A. Representative whole cell recordings from cells transfected with nontargeting siRNA (mock) (A) or with TMEM16A siRNA (B) in presence of PKC␣ (60 ng/ml) in dialyzing pipette. The voltagestep protocol (400-ms steps from Ϫ100 to ϩ100 mV in 20-mV increments) was obtained at aଝ and bଝ as indicated and used to generate the I-V relation during initial () and PKC␣-stimulated conditions (OE). C: cumulative data demonstrating maximal current density (ϪpA/ pF) measured at Ϫ80 mV in the presence of PKC␣ in nontransfected (control) cells, cells transfected with nontargeting siRNA (mock), or cells transfected with TMEM16A siRNA. Bars represent means Ϯ SE; n ϭ 5-6. *P Ͻ 0.01, peak currents (control) vs. basal currents. øP Ͻ 0.01, peak currents (mock) vs. basal currents. #P Ͻ 0.05, peak currents (siRNA) vs. basal currents. **P Ͻ 0.01, peak currents with TMEM16A siRNA vs. control or mock transfected. D: cumulative data demonstrating change in TMEM16A, mRNA (top) and representative Western blot (bottom) protein levels in control cells, cells transfected with nontargeting siRNA (mock), and cells transfected with anti-TMEM16A siRNA. *P Ͻ 0.05 vs. control or mock levels; n ϭ 6 each. eration, precedes the translocation event (8) . In other models, the translocation of PKC␣ is a result of Ca 2ϩ interaction with the C2 domain leading to a structural change and binding to plasma membrane targets (21) . Once PKC is located at plasma membrane sites, further Ca 2ϩ binding increases the dwell time of PKC␣ in the membrane and may potentially lead to regulation of other Ca 2ϩ -dependent processes, such as channel activation (24) . Furthermore, the potential structural basis for the Ca 2ϩ and PKC synergy on channel activation observed in our studies is unknown. Presumably, this may occur through changes in the folding of the structural domain or conformational changes of PKC␣ and/or the channel protein in response to Ca 2ϩ . Third, our studies demonstrate that TMEM16A is a target of ATP-stimulated PKC␣ activity; however, it may not be the sole target and ATP-stimulated PKC␣ activity may regulate other membrane channel proteins. In fact, in the majority of studies in which delivery of recombinant PKC␣ to the cell interior resulted in Cl Ϫ currents, the Ca 2ϩ -activated Cl Ϫ currents were preceded by Ca 2ϩ -activated K ϩ currents. The molecular identification of these PKC␣-stimulated K ϩ channels is unknown; however, two Ca 2ϩ -activated K ϩ channels have previously been identified in biliary cells including the small and intermediate conductance Ca 2ϩ -activated K ϩ channels SK2 (11) and IK1 (7). In secretory epithelium it is felt that activation of K ϩ channels leads to membrane hyperpolarization to maintain the electrical driving force for continued Cl Ϫ efflux (5). Thus PKC may represent a central regulator by integrating different stimuli into coordinated secretory responses through effects on distinct channel proteins, including Cl Ϫ and K ϩ channels. Lastly, while PKC␣ is the predominant isoform linking P2 receptors to TMEM16A activation, other PKC isoforms may be involved in other steps in the purinergic-signaling pathway in which separate isoforms may respond to different stimuli. For example, we have previously shown that while ATP release in response to cell swelling, which involves exocytosis of ATP-containing vesicles (14, 29) , is dependent on conventional PKC isoforms, fluid-flow-or shear-stress-induced ATP release is dependent on the atypical isoform PKC (35) . Thus distinct PKC isoforms exist in BECs and their activity changes in response to different stimuli to coordinate a regulated physiologic response. Of course other volume-sensitive pathways exist in liver cells as well, including tyrosine kinase and MAP kinase pathways (10, 13) . This paradigm, with distinct mechanical stimuli, multiple kinase signaling pathways, and various effector pathways, represents a means to coordinate and integrate various cellular signals with fidelity and specificity and a way to fine-tune membrane transport over a broad range of stimuli. The mechanism by which different mechanical stimuli activate specific and distinct kinase signaling cascades, the potential interaction between PKC isoforms and other protein kinases, and the target effector channels will require further study.
In summary, our studies demonstrate that PKC␣ is coupled to ATP-stimulated TMEM16A activation in BECs. This ATPCa 2ϩ -PKC␣ signaling pathway is an important regulator of BEC Cl Ϫ secretion and therefore may represent a potential target to promote bile formation.
